Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form, in dosage forms and in the presence of its oxidative degradates

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy

Volumn 59, Issue 4, 2003, Pages 695-703

  Amin, A S ^a   Ahmed, I S ^a   Dessouki, H A ^a   Gouda, E A ^a  

^a BENHA UNIVERSITY   (Egypt)

Author keywords

bromosuccinimide; Cerium(IV) sulfate; Dosage forms; Oxidation reaction; Ranitidine HCl; Spectrophotometry

Indexed keywords

LIGHT ABSORPTION; REDOX REACTIONS; REGRESSION ANALYSIS; SPECTROPHOTOMETRY;

CHROMOTROPES;

DRUG PRODUCTS;

BROMIDE; CERIUM; CERIUM SULFATE; COLORING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; N BROMOSUCCINIMIDE; OXYGEN; POTASSIUM BROMIDE; POTASSIUM DERIVATIVE; RANITIDINE; SULFATE;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; METHODOLOGY; OXIDATION REDUCTION REACTION; REGRESSION ANALYSIS; SPECTROPHOTOMETRY; TEMPERATURE; TIME;

BROMIDES; BROMOSUCCINIMIDE; CERIUM; COLORING AGENTS; HISTAMINE H2 ANTAGONISTS; MODELS, CHEMICAL; OXIDATION-REDUCTION; OXYGEN; POTASSIUM COMPOUNDS; RANITIDINE; REGRESSION ANALYSIS; SPECTROPHOTOMETRY; SULFATES; TEMPERATURE; TIME FACTORS;

EID: 0037370421     PISSN: 13861425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-1425(02)00226-3     Document Type: Article

References (33)

1. American Hospital Formulary Service (AHFS), Drug Information, G.K. Mc Evoy (Ed.) Authority of the Broad of Directors of the American Society of Hospital Pharmacists, Bethesda, MD, USA, 1990, pp. 1190-1694.
2. Vinas P., Campillo N., Lopez-Erroz C., Hernandez Cordoba M. J. Chromatogr. B Biomed. Appl. 693:1997;443.
3. El-Bayoumi A.E.-A., El-Shanawany A., El-Sadek M.E., El-Sattar A.A. J. Pharm. Biomed. Anal. 21:1999;867.
4. Novakovie J. J. Chromatogr. A. 846:1999;193.
5. Farthing D., Brouwer K.L.R., Fakhry I., Sica D. J. Chromatogr. B Biomed. Appl. 688:1997;350.
6. Wong C.F., Peh K.K., Yuen K.H. J. Chromatogr. B Biomed. Appl. 718:1998;205.
7. Ho C., Haung H.M., Hsu S.Y., Shaw C.Y., Chang B.L. Drug Dev. Ind. Pharm. 25:1999;379.
8. Squella J.A., Zuniga L.A., Lemus I., Nunez-vergara L.J. J. Assoc. Off. Anal. Chem. 71:1988;388.
9. Richter P., Ines Toral M., Munozvargas F. Analyst. 119:1994;1371.
10. Sankar P.S., Reddy S.J. Indian J. Pharm. Sci. 51:1989;263.
11. Altinoz S., Ozer D., Temizer A., Bayraktar Y. Anal. Lett. 25:1992;111.
12. Mitsana-Papazoglou A., Diamandis E.P., Hadjiioannou T.P. J. Pharm. Sci. 76:1987;485.
13. Atkosar Z., Tuncel M. Acta Pharm. Turc. 31:1989;139.
14. Liu H., Huang C.L., Xiu R. Fenxi Kexue Xuebao. 16:2000;27.
15. Raut K.N., Sabnis S.D. Indian J. Pharm. Sci. 49:1987;65.
16. Rao E.V., Rao P.J., Murty S.S.N., Rao G.R. Indian J. Pharm. Sci. 49:1987;143.
17. Sadana G.S., Ozarkar S.G., Nayak V.G. Indian Drugs. 23:1986;573.
18. Emmanuel J., Haldankar S.D. Indian Drugs. 26:1989;249.
19. Rao G.R., Auadhanulu A.B., Vasta D.K. Indian Drugs. 27:1989;135.
20. Hassan S.S.M., Mahmoud W.H., Othman A.H.M. Anal. Chim. Acta. 332:1996;39.
21. Abdel Kader S.A., Abdel Kawy M., Nebsen M. Anal. Lett. 32:1999;1403.
22. Sastry C.S.P., Rao S.G., Rao J.S.V.M.L., Naidu P.Y. Anal. Lett. 30:1997;2377.
23. Girish Kumar K., Indrasenan P. J. Pharm. Biomed. Anal. 7:1989;627.
24. Girish Kumar K., Indrasenan P. Analyst. 113:1988;1369.
25. Sastry C.S.P., Srinivas K.R., Prasad K.M.M.K. Talanta. 43:1996;1625.
26. Sastry C.S.P., Naidu P.Y. Mikrochim. Acta. 127:1997;219.
27. Girish Kumar K., Jaya Shree R. J. Pharm. Biomed. Anal. 11:1993;165.
28. Rizk M.S., Issa Y.M., Snoukry A.F., Atia E.M. Anal. Lett. 30:1997;2743.
29. Ayad M.M., Shalaby A.A., Abdel Latef H.E., El-Said H.M. J. Pharm. Biomed. Anal. 20:1999;557.
30. Sultan S.M., Hassan Y.A.M., Ibrahim K.E.E. Analyst. 124:1999;917.
31. Vogel's a Text Book of Quantitative Inorganic Analysis, vol. I, 1978, p. 298.
32. IUPAC, Spectrochim. Acta, Part B 33 (1978) 242.
33. British Pharmacopoeia, vol. I, Her Majesty's Stationary Office, London, 1998, p. 1134.